Cyberonics to Present at Citi 2011 Global Health Care Conference

HOUSTON, Feb. 17, 2011 /PRNewswire/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the Citi 2011 Global Health Care Conference in New York on Thursday, March 3, 2011 at 11:00 AM Eastern Time.  A live audio webcast of the presentation can be accessed by clicking on the Investors link on the Cyberonics home page at http://www.cyberonics.com on March 3, 2011.  The conference webcast replay will be available for 90 days following the conference.  Access to the webcast is not password protected.

About Cyberonics, Inc. and the VNS Therapy® System

Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation.  The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.

Contact Information

Greg Browne, CFO

Cyberonics, Inc.

100 Cyberonics Blvd.

Houston, TX 77058

Main:  (281) 228-7262

Fax:  (281) 218-9332

[email protected]



SOURCE Cyberonics, Inc.

Suggested Articles

Novartis is rolling out positive interim phase 3 data on Zolgensma in Europe, which could support the recent launch of the SMA gene therapy there.

The new cost-cutting goal comes on top of a €2.6 billion annual savings target the company already laid out in a revamp initiated in 2018.

As hearings continued on Capitol Hill, a congressional committee said Novartis, Amgen and Mallinckrodt used routine price hikes to meet sales targets.